St Vincents Cancer Study to Commence-NOX66 and Radiotherapy
Filed with ASX · · 3 pages · English
Story so far
Earlier from Noxopharm
- NOX makes strategic commitment to treatment of rare cancers
- Market Guidance for Next Six Months
- NOX Files Patent Application on Smart Idronoxil
- NOX and Monash Uni Collaboration Receives Federal Grant
- Noxopharm and UNSW combine on stroke project
Later from Noxopharm
- NOX66 confirmed Non-Toxic. Trial Cleared for Full Enrolment
- Idronoxil data provides hope to treat secondary brain cancer
- Noxopharm provides update on NOX66 Clinical Trial Program
- Suspension from Official Quotation
- Noxopharm raises $5.5 million to advance clinical program
Follow Noxopharm into a list and get an email when it puts out news.
Follow Noxopharm